HOME >> BIOLOGY >> NEWS
Nilotinib appears to help chronic myelogenous leukemia patients when standard care fails

HOUSTON -- The targeted agent nilotinib (AMN107) appears to offer striking benefits in patients with chronic myelogenous leukemia (CML) who are resistant to Gleevec, the standard therapy for this cancer, say researchers at The University of Texas M. D. Anderson Cancer Center.

Results of a 119-patient, phase I dose-escalation study, published June 15 in The New England Journal of Medicine, show that nilotinib offers a relatively favorable safety profile and obvious activity, researchers say, even though the study was not designed to measure the agent's effectiveness.

"We are very excited about this drug," says the study's lead investigator, Hagop Kantarjian, M.D., professor and chair of the Department of Leukemia. "With it, I believe we are going to make another quantum leap in the treatment of CML, allowing us to treat our patients according to their cancer's distinct molecular signature."

Nilotinib is the younger sibling of Gleevec, both of which were developed by Novartis Pharmaceuticals Corporation, which also funded the study. Preclinical studies have shown that nilotinib, which is administered in pill form, is up to 50 times more potent than Gleevec because it was designed to more efficiently bind to, and shut down, the protein enzyme responsible for the disease.

The June 15 NEJM also includes a report on a phase 1 clinical trial for dasatinib, a medication developed by Bristol-Myers Squibb for CML and acute lymphoblastic leukemia, and an editorial noting the importance of both papers' findings for CML patients and for swift, targeted drug development based on an understanding of cancer at the molecular level.

While Kantarjian notes that nilotinib seems to have fewer side effects than Gleevec, which is considered a safe drug, some patients in this trial were found to have abnormal electrical activity in their hearts, and one patient experienced two cardiac events. "We believe this issue is manageable with the right do
'"/>

Contact: Scott Merville
sdmervil@mdanderson.org
713-792-0661
University of Texas M. D. Anderson Cancer Center
14-Jun-2006


Page: 1 2 3 4

Related biology news :

1. Risk of common vaginal infection linked to preterm birth appears higher for blacks
2. Risk of preterm birth appears to vary by season
3. Prenatal alcohol exposure appears to increase an infants stress response
4. Red grapefruit appears to lower cholesterol, fight heart disease
5. Vanadium appears to play role in speeding recovery from infections
6. UT Southwestern researchers uncover gene variant that appears to predict type 2 diabetes
7. Ingestion of afterbirth appears to promote maternal behavior in mammals
8. Protein adiponectin appears protective against heart disease
9. Birds, butterflies, bacteria same law of biology appears to apply
10. Brain-derived neurotrophic factor (BDNF) appears to modify elements of alcoholism
11. NIAID supports research into etiology of fungal-induced inflammation in chronic sinusitis

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/4/2019)... ... 2019 , ... Harper was three years old when her owners took her ... caused painful osteoarthritis in the joints. She was referred to a veterinary specialist ... surgical specialist, Dr. Christopher Eich of Southern California Veterinary Specialty Hospital , examined ...
(Date:6/4/2019)... ... June 04, 2019 , ... Lajollacooks4u is delighted to announce it has been ... hospitality excellence, is given only to businesses that have achieved consistently outstanding traveler reviews ... , To qualify for the Certificate of Excellence –- an award that ...
(Date:6/1/2019)... ... 31, 2019 , ... The University of Vermont Health Network ... $6M Series B Financing Round. , “With the commitment from the UVM ... financial and business resources to bear as we advance our biopharmaceutical products to ...
Breaking Biology News(10 mins):
(Date:5/31/2019)... N.C. (PRWEB) , ... May 30, 2019 , ... ... is the first to demonstrate an efficient delivery system for the sustained release ... injuries. The platelet-rich plasma-based gel system was able to deliver CM into the ...
(Date:5/15/2019)... ... May 16, 2019 , ... Emulsifiers are ... food and beverage products rely on these ingredients to create stable quality food ... declarations. This paradigm shift triggers food formulators to seek out alternatives for starches, ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The new ... number of repositories being asked to store cellular products being used in ... contributors who are world leaders, who have shared their expertise in building and ...
(Date:5/2/2019)... ... April 30, 2019 , ... The centuries old practice of brewing beer ... local craft breweries, and even home brewing clubs scattered across the nation. , ... that when mastered can produce a superb product. Students at South Dakota School ...
Breaking Biology Technology:
Cached News: